JP2016105737A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016105737A5 JP2016105737A5 JP2016052380A JP2016052380A JP2016105737A5 JP 2016105737 A5 JP2016105737 A5 JP 2016105737A5 JP 2016052380 A JP2016052380 A JP 2016052380A JP 2016052380 A JP2016052380 A JP 2016052380A JP 2016105737 A5 JP2016105737 A5 JP 2016105737A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- nucleic acid
- seq
- protein
- cultured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 22
- 102000039446 nucleic acids Human genes 0.000 claims 14
- 108020004707 nucleic acids Proteins 0.000 claims 14
- 150000007523 nucleic acids Chemical class 0.000 claims 14
- 238000000034 method Methods 0.000 claims 12
- 235000018102 proteins Nutrition 0.000 claims 12
- 102000004169 proteins and genes Human genes 0.000 claims 12
- 108090000623 proteins and genes Proteins 0.000 claims 12
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims 4
- AEMOLEFTQBMNLQ-HNFCZKTMSA-N L-idopyranuronic acid Chemical compound OC1O[C@@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-HNFCZKTMSA-N 0.000 claims 4
- UGJBHEZMOKVTIM-UHFFFAOYSA-N N-formylglycine Chemical compound OC(=O)CNC=O UGJBHEZMOKVTIM-UHFFFAOYSA-N 0.000 claims 4
- 102000005262 Sulfatase Human genes 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 108060007951 sulfatase Proteins 0.000 claims 4
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims 3
- 238000004113 cell culture Methods 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 2
- 210000004962 mammalian cell Anatomy 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 239000002609 medium Substances 0.000 claims 1
- 230000010412 perfusion Effects 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 239000012679 serum free medium Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 238000004114 suspension culture Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261666719P | 2012-06-29 | 2012-06-29 | |
| US61/666,719 | 2012-06-29 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015520569A Division JP6067849B2 (ja) | 2012-06-29 | 2013-06-28 | 組換えイズロン酸２スルファターゼを製造するための細胞 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018037376A Division JP6755272B2 (ja) | 2012-06-29 | 2018-03-02 | 組換えイズロン酸２スルファターゼを製造するための細胞 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016105737A JP2016105737A (ja) | 2016-06-16 |
| JP2016105737A5 true JP2016105737A5 (enExample) | 2016-08-12 |
| JP6302499B2 JP6302499B2 (ja) | 2018-03-28 |
Family
ID=49778522
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015520569A Active JP6067849B2 (ja) | 2012-06-29 | 2013-06-28 | 組換えイズロン酸２スルファターゼを製造するための細胞 |
| JP2016052380A Active JP6302499B2 (ja) | 2012-06-29 | 2016-03-16 | 組換えイズロン酸２スルファターゼを製造するための細胞 |
| JP2018037376A Active JP6755272B2 (ja) | 2012-06-29 | 2018-03-02 | 組換えイズロン酸２スルファターゼを製造するための細胞 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015520569A Active JP6067849B2 (ja) | 2012-06-29 | 2013-06-28 | 組換えイズロン酸２スルファターゼを製造するための細胞 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018037376A Active JP6755272B2 (ja) | 2012-06-29 | 2018-03-02 | 組換えイズロン酸２スルファターゼを製造するための細胞 |
Country Status (27)
| Country | Link |
|---|---|
| US (3) | US9150841B2 (enExample) |
| EP (1) | EP2874649B1 (enExample) |
| JP (3) | JP6067849B2 (enExample) |
| KR (1) | KR101710487B1 (enExample) |
| CN (2) | CN107267460A (enExample) |
| AU (3) | AU2013282400B2 (enExample) |
| BR (1) | BR112014032560B1 (enExample) |
| CA (1) | CA2877521C (enExample) |
| CL (1) | CL2014003568A1 (enExample) |
| CO (1) | CO7240394A2 (enExample) |
| CR (1) | CR20140586A (enExample) |
| DO (1) | DOP2014000298A (enExample) |
| EA (2) | EA202090805A1 (enExample) |
| ES (1) | ES2718346T3 (enExample) |
| GT (1) | GT201400302A (enExample) |
| HK (1) | HK1209331A1 (enExample) |
| IL (3) | IL236343A (enExample) |
| MX (2) | MX336716B (enExample) |
| MY (2) | MY189314A (enExample) |
| NZ (2) | NZ734670A (enExample) |
| PE (1) | PE20150957A1 (enExample) |
| PH (2) | PH12016500011B1 (enExample) |
| SG (2) | SG11201408702VA (enExample) |
| TR (1) | TR201904435T4 (enExample) |
| UA (1) | UA118955C2 (enExample) |
| WO (1) | WO2014005019A2 (enExample) |
| ZA (1) | ZA201409396B (enExample) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| ES3005233T3 (en) | 2010-10-01 | 2025-03-14 | Modernatx Inc | Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| JP2014511687A (ja) | 2011-03-31 | 2014-05-19 | モデルナ セラピューティクス インコーポレイテッド | 工学操作された核酸の送達および製剤 |
| US20160145589A1 (en) | 2011-06-24 | 2016-05-26 | Green Cross Corporation | Composition and formulation comprising recombinant human iduronate-2-sulfatase and preparation method thereof |
| JP2015501844A (ja) | 2011-12-16 | 2015-01-19 | モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 修飾ヌクレオシド、ヌクレオチドおよび核酸組成物 |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US9254311B2 (en) | 2012-04-02 | 2016-02-09 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of proteins |
| WO2013151663A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of membrane proteins |
| BR112014027378A2 (pt) * | 2012-05-02 | 2017-06-27 | Life Technologies Corp | expressão transiente de alto rendimento em células de mamíferos usando pareamento exclusivo de crescimento de alta densidade e meio de transfecção e potenciadores de expressão |
| KR101380740B1 (ko) | 2012-06-29 | 2014-04-11 | 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 | 이듀로네이트-2-설파타제의 정제 |
| US20140004097A1 (en) * | 2012-06-29 | 2014-01-02 | Shire Human Genetic Therapies, Inc. | Method of producing recombinant iduronate-2-sulfatase |
| US9150841B2 (en) * | 2012-06-29 | 2015-10-06 | Shire Human Genetic Therapies, Inc. | Cells for producing recombinant iduronate-2-sulfatase |
| WO2014028429A2 (en) | 2012-08-14 | 2014-02-20 | Moderna Therapeutics, Inc. | Enzymes and polymerases for the synthesis of rna |
| ES2921623T3 (es) | 2012-11-26 | 2022-08-30 | Modernatx Inc | ARN modificado terminalmente |
| US20160024181A1 (en) | 2013-03-13 | 2016-01-28 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| US10258698B2 (en) | 2013-03-14 | 2019-04-16 | Modernatx, Inc. | Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions |
| WO2015048744A2 (en) | 2013-09-30 | 2015-04-02 | Moderna Therapeutics, Inc. | Polynucleotides encoding immune modulating polypeptides |
| US9550972B2 (en) | 2014-09-29 | 2017-01-24 | General Electric Company | Devices, systems and methods for automated cell culturing |
| EP3101125A1 (en) * | 2015-06-05 | 2016-12-07 | Laboratorios Del Dr. Esteve, S.A. | Adenoassociated virus vectors for the treatment of mucopolysaccharidoses |
| EP3359670B2 (en) | 2015-10-05 | 2024-02-14 | ModernaTX, Inc. | Methods for therapeutic administration of messenger ribonucleic acid drugs |
| MX2020002918A (es) | 2017-10-02 | 2020-07-22 | Denali Therapeutics Inc | Proteinas de fusion que comprenden enzimas de terapia de reemplazo de enzimas. |
| JP7060235B2 (ja) * | 2018-05-18 | 2022-04-26 | 国立大学法人広島大学 | 変異型イズロン酸－２－スルファターゼの機能回復薬剤のスクリーニング方法 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK6488D0 (da) | 1988-01-07 | 1988-01-07 | Novo Industri As | Enzymer |
| US5310646A (en) | 1988-05-13 | 1994-05-10 | Regents Of The University Of Minnesota | Method for the detection of mucopolysaccharide storage diseases |
| US5932211A (en) | 1991-11-12 | 1999-08-03 | Women's And Children's Hospital | Glycosylation variants of iduronate 2-sulfatase |
| AU700369B2 (en) | 1994-03-16 | 1999-01-07 | Regents Of The University Of California, The | Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor |
| US5863782A (en) | 1995-04-19 | 1999-01-26 | Women's And Children's Hospital | Synthetic mammalian sulphamidase and genetic sequences encoding same |
| DE19527054A1 (de) | 1995-07-26 | 1997-01-30 | Behringwerke Ag | Verfahren zur Charakterisierung der Glycosylierung von Glycoproteinen sowie zur in-vitro Bestimmung der Bioverfügbarkeit von Glycoproteinen |
| EP2243827B2 (en) | 1996-08-30 | 2017-11-22 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
| US7368531B2 (en) | 1997-03-07 | 2008-05-06 | Human Genome Sciences, Inc. | Human secreted proteins |
| AU3382800A (en) | 1999-02-26 | 2000-09-14 | Millennium Pharmaceuticals, Inc. | Secreted proteins and uses thereof |
| US7083793B2 (en) | 1999-02-26 | 2006-08-01 | Millennium Pharmaceuticals, Inc. | Tango 243 polypeptides and uses thereof |
| ATE348173T1 (de) | 1999-04-26 | 2007-01-15 | Genentech Inc | Zellenzuchtverfahren für glycoproteine |
| JP2002017376A (ja) | 1999-07-08 | 2002-01-22 | Herikkusu Kenkyusho:Kk | 分泌蛋白質、または膜蛋白質 |
| CA2383800A1 (en) | 1999-09-03 | 2001-03-15 | Human Genome Sciences Inc. | 52 human secreted proteins |
| US6780627B1 (en) | 2000-01-31 | 2004-08-24 | Millennium Pharmaceuticals, Inc. | 22438, 23553, 25278, and 26212 novel human sulfatases |
| CA2400034A1 (en) | 2000-02-17 | 2001-08-23 | Incyte Genomics, Inc. | Human kinases |
| EP1268541A1 (en) | 2000-03-17 | 2003-01-02 | Human Genome Sciences, Inc. | 7 human ovarian and ovarian cancer associated proteins |
| EP1274720A4 (en) | 2000-04-12 | 2004-08-18 | Human Genome Sciences Inc | FUSION PROTEINS CONTAINING ALBUMIN |
| US20030148920A1 (en) | 2000-12-27 | 2003-08-07 | Steven Rosen | Sulfatases and methods of use thereof |
| WO2002098455A2 (en) | 2001-06-07 | 2002-12-12 | Hemebiotech A/S | Production of recombinant human arylsulfatase a |
| DK1501369T3 (en) | 2002-04-26 | 2015-09-28 | Genentech Inc | Non-affinity purification of proteins |
| US6890736B1 (en) | 2002-09-20 | 2005-05-10 | Immunex Corporation | Methods for producing proteins in cultured cells |
| AU2003300276B2 (en) | 2002-12-23 | 2010-07-01 | Bristol-Myers Squibb Company | Mammalian cell culture processes for protein production |
| CN101444621B (zh) | 2003-02-11 | 2013-11-20 | 夏尔人类遗传性治疗公司 | 使用甲酰-甘氨酸生成酶(fge)对多种硫酸酯酶缺乏症和其它病症进行诊断和治疗 |
| US20050019914A1 (en) | 2003-07-24 | 2005-01-27 | Aventis Pharma Deutschland Gmbh | Perfusion process for producing erythropoietin |
| WO2005113765A2 (en) | 2004-05-06 | 2005-12-01 | Biomarin Pharmaceutical Inc. | Methods of activation of sulfatases and methods and compositions of using the same |
| ES2385639T3 (es) | 2005-06-03 | 2012-07-27 | Ares Trading S.A. | Producción de una proteína de unión a IL-18 recombinante |
| EP2001898A1 (en) | 2006-03-20 | 2008-12-17 | Medarex Inc. | Protein purification |
| EP2245145B1 (en) | 2008-01-18 | 2016-12-14 | BioMarin Pharmaceutical Inc. | Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof |
| SI2485761T1 (sl) | 2009-10-09 | 2019-05-31 | Armagen, Inc. | Postopki in sestavki za povečanje aktivnosti iduronat-2-sulfataze v CŽS |
| CN105664811B (zh) * | 2009-10-09 | 2018-10-09 | 蓝立方知识产权公司 | 生产氯化和/或氟化丙烯和高级烯烃的绝热活塞流反应器及方法 |
| WO2011108451A1 (ja) | 2010-03-01 | 2011-09-09 | 日本ケミカルリサーチ株式会社 | 遺伝子ノックアウト細胞を用いた組換え体リソソーム酵素の製造方法 |
| UA115649C2 (uk) | 2010-06-25 | 2017-12-11 | Шае Хюмен Дженетік Терапіс, Інк. | Способи та композиції для доставки до цнс ідуронат-2-сульфатази |
| WO2012101671A1 (en) | 2011-01-25 | 2012-08-02 | Jcr Pharmaceuticals Co., Ltd. | Method for production of human recombinant iduronate 2-sulfatase |
| KR101158673B1 (ko) * | 2011-06-24 | 2012-07-03 | 주식회사 지씨바이오 | 재조합 인간 이듀로네이트-2-설파타아제를 포함하는 조성물, 제제 및 이의 제조방법 |
| US20140004097A1 (en) | 2012-06-29 | 2014-01-02 | Shire Human Genetic Therapies, Inc. | Method of producing recombinant iduronate-2-sulfatase |
| US9150841B2 (en) * | 2012-06-29 | 2015-10-06 | Shire Human Genetic Therapies, Inc. | Cells for producing recombinant iduronate-2-sulfatase |
| KR101380740B1 (ko) | 2012-06-29 | 2014-04-11 | 쉐어 휴먼 제네텍 세러피스, 인코포레이티드 | 이듀로네이트-2-설파타제의 정제 |
-
2013
- 2013-03-14 US US13/829,780 patent/US9150841B2/en active Active
- 2013-06-28 NZ NZ734670A patent/NZ734670A/en unknown
- 2013-06-28 BR BR112014032560-0A patent/BR112014032560B1/pt active IP Right Grant
- 2013-06-28 TR TR2019/04435T patent/TR201904435T4/tr unknown
- 2013-06-28 MY MYPI2016000156A patent/MY189314A/en unknown
- 2013-06-28 HK HK15110031.3A patent/HK1209331A1/xx unknown
- 2013-06-28 JP JP2015520569A patent/JP6067849B2/ja active Active
- 2013-06-28 EP EP13810018.5A patent/EP2874649B1/en active Active
- 2013-06-28 PH PH1/2016/500011A patent/PH12016500011B1/en unknown
- 2013-06-28 CN CN201710300757.6A patent/CN107267460A/zh active Pending
- 2013-06-28 NZ NZ703137A patent/NZ703137A/en unknown
- 2013-06-28 SG SG11201408702VA patent/SG11201408702VA/en unknown
- 2013-06-28 EA EA202090805A patent/EA202090805A1/ru unknown
- 2013-06-28 UA UAA201413829A patent/UA118955C2/uk unknown
- 2013-06-28 PE PE2014002538A patent/PE20150957A1/es not_active Application Discontinuation
- 2013-06-28 MX MX2015000189A patent/MX336716B/es unknown
- 2013-06-28 SG SG10201509397SA patent/SG10201509397SA/en unknown
- 2013-06-28 CN CN201380037937.XA patent/CN104540517A/zh active Pending
- 2013-06-28 WO PCT/US2013/048571 patent/WO2014005019A2/en not_active Ceased
- 2013-06-28 AU AU2013282400A patent/AU2013282400B2/en active Active
- 2013-06-28 ES ES13810018T patent/ES2718346T3/es active Active
- 2013-06-28 CA CA2877521A patent/CA2877521C/en active Active
- 2013-06-28 KR KR1020157000841A patent/KR101710487B1/ko active Active
- 2013-06-28 MY MYPI2014003485A patent/MY157086A/en unknown
- 2013-06-28 MX MX2016001229A patent/MX366155B/es unknown
- 2013-06-28 EA EA201492183A patent/EA035511B1/ru not_active IP Right Cessation
-
2014
- 2014-12-17 CR CR20140586A patent/CR20140586A/es unknown
- 2014-12-18 IL IL236343A patent/IL236343A/en active IP Right Grant
- 2014-12-19 ZA ZA2014/09396A patent/ZA201409396B/en unknown
- 2014-12-22 PH PH12014502868A patent/PH12014502868A1/en unknown
- 2014-12-22 DO DO2014000298A patent/DOP2014000298A/es unknown
- 2014-12-26 CO CO14284192A patent/CO7240394A2/es unknown
- 2014-12-29 GT GT201400302A patent/GT201400302A/es unknown
- 2014-12-29 CL CL2014003568A patent/CL2014003568A1/es unknown
-
2015
- 2015-08-21 US US14/832,728 patent/US9719074B2/en active Active
-
2016
- 2016-01-27 AU AU2016200460A patent/AU2016200460B2/en active Active
- 2016-03-16 JP JP2016052380A patent/JP6302499B2/ja active Active
-
2017
- 2017-07-14 US US15/650,536 patent/US20180010108A1/en not_active Abandoned
- 2017-09-18 IL IL254560A patent/IL254560B/en active IP Right Grant
-
2018
- 2018-01-30 AU AU2018200710A patent/AU2018200710B2/en active Active
- 2018-03-02 JP JP2018037376A patent/JP6755272B2/ja active Active
-
2020
- 2020-04-27 IL IL274266A patent/IL274266B/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015521848A5 (enExample) | ||
| JP2014524241A5 (enExample) | ||
| IN2014DN03419A (enExample) | ||
| IN2012DN00899A (enExample) | ||
| MX2012003654A (es) | Metodos de produccion de glucoproteinas en cultivos de celulas de mamiferos usando glucocorticoides. | |
| JP2022552183A5 (enExample) | ||
| WO2011091350A3 (en) | Methods & compositions for improving protein production | |
| PH12015501837B1 (en) | Manufacturing methods to control c-terminal lysine, galactose and sialic acid content in recombinant proteins | |
| NZ602958A (en) | High level expression of recombinant toxin proteins | |
| EA201991976A1 (ru) | Метаболически оптимизированная клеточная культура | |
| BRPI0409895B8 (pt) | método de cultura de células derivadas de células per.c6 capazes de crescer em suspensão para aumentar o rendimento de produto das referidas células | |
| WO2011075686A3 (en) | Methods & compositions comprising heat shock proteins | |
| IL276211B2 (en) | HU14.18K322A monoclonal antibody production process | |
| PH12013502600A1 (en) | Rabies virus like particle production in plants | |
| JP2015523074A5 (enExample) | ||
| PH12014500640A1 (en) | Increasing virus-like particle yield in plants | |
| CN102586190B (zh) | 高效表达重组人神经生长因子的cho细胞株及其构建方法 | |
| JP2016513457A5 (enExample) | ||
| JP2021529527A5 (enExample) | ||
| CN103266137A (zh) | 一种角鲨烯的生产方法 | |
| CN105368808A (zh) | 一种IdeS蛋白酶、其制备方法及应用 | |
| CN104531725A (zh) | 一种可被4’磷酸泛酰巯基乙胺修饰的序列及其用于固定蛋白质的方法 | |
| CN102911960B (zh) | 一种减弱反馈抑制菌株生产谷胱甘肽的方法 | |
| CN102199623A (zh) | 蛋白质精氨酸甲基转移酶5的新用途 | |
| RU2015105274A (ru) | СПОСОБ ПОЛУЧЕНИЯ БЕЛКОВ СЕМЕЙСТВА ЦИСТЕИНОВЫХ ПРОТЕАЗ ПШЕНИЦЫ (Triticum aestivum) И ПРЕПАРАТ БЕЛКА ТРИТИКАИН-АЛЬФА, ПОЛУЧЕННЫЙ ЭТИМ СПОСОБОМ |